Vanguard Health Care Index Fund (VHT)

  • Loading...

Best Fit Health/Biotechnology Funds ETFs

U.S. News evaluated 29 Health/Biotechnology Funds ETFs and 14 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.

How we identify Best Fit Funds

Best Fit Scorecard
Costs Excellent
Tracking Error Excellent
Bid/Ask Ratio Typical
Holdings Diversity Good

Fund Description

The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). It attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.

Fund Snapshot Updated 07.22.2014

Previous Close $112.49 Expense Ratio 0.14%
YTD Return 11.28% Avg. 30-Day Volume 150,058
1-Year Return 23.2% Market Cap Loading...
Bid $112.46 Shares Outstanding 27,423,000
Ask $112.48 Dividends $1.14
Top 10 Holdings
Johnson & Johnson (JNJ) 10.27%
Pfizer Inc (PFE) 6.90%
Merck & Co Inc New (MRK) 6.09%
Gilead Sciences Inc (GILD) 4.87%
Amgen Inc (AMGN) 3.24%
Abbvie Inc (ABBV) 3.04%
Unitedhealth Group Inc (UNH) 3.02%
Bristol Myers Squibb Co (BMY) 2.87%
Biogen Idec Inc (BIIB) 2.54%
Celgene Corp (CELG) 2.49%
% of Total Holdings 45.30%

Sector Breakdown

Geographic Breakdown

Best Fit Health/Biotechnology Funds

See full rankings for Health/Biotechnology Funds